INTEGRATING STRUCTURAL BIOLOGY TECHNIQUES TO UNDERSTAND ENDOGENOUS SRC-FAMILY KINASE INHIBITION TOWARD THE DEVELOPMENT OF NOVEL ANTI-CANCER DRUGS